Dianthus Therapeutics CEO Jason Gardner's 2021 pay falls 28% to $2.2M
Dianthus Therapeutics reports 2021 executive compensation
By ExecPay News
Published: May 2, 2022
Dianthus Therapeutics reported fiscal year 2021 executive compensation information on May 2, 2022.
In 2021, three executives at Dianthus Therapeutics received on average a compensation package of $1.9M, a 15% decrease compared to previous year.
Average pay of disclosed executives at Dianthus Therapeutics
Jason Gardner, Chief Executive Officer, received $2.2M in total, which decreased by 28% compared to 2020. 62% of Gardner's compensation, or $1.4M, was in option awards. Gardner also received $300K in non-equity incentive plan, $545K in salary, as well as $5.4K in other compensation.
Thomas Beetham, Chief Legal Officer, received a compensation package of $1.9M. 83% of the compensation package, or $1.6M, was in option awards.
David Nichols, Chief Technical Officer, earned $1.7M in 2021.
Related executives
You may also like
Source: SEC filing on May 2, 2022.